(1)
Webster, MD, L.; Tummala, MD, MBA, MS, R.; Diva, PhD, U.; Lappalainen, MD, PhD, J. A 12-Week Extension Study to Assess the Safety and Tolerability of Naloxegol in Patients With Noncancer Pain and Opioid-Induced Constipation. J of Opioid Management 2016, 12, 405-419.